Caine Leong
About
Caine Leong is from Singapore. Caine works in the following industries: "Biotechnology". Caine is currently General Manager, Asia Pacific - Merck BioReliance® Contract Testing Services at Merck Life Science, located in Singapore. In Caine's previous role as a Head of Commercial, Asia Pacific at Merck Life Science, Caine worked in Singapore, Singapore until Sep 2025. Prior to joining Merck Life Science, Caine was a Head of Sales, APAC, Contract Testing Services at Merck Life Science and held the position of Head of Sales, APAC, Contract Testing Services at Singapore. Prior to that, Caine was a Life Science Group Manager, Southeast Asia at Bio-Rad Laboratories, based in Singapore from Aug 2017 to Aug 2019. Caine started working as Marketing Director, Asia at Pall Corporation in Singapore in Mar 2013. From Aug 2013 to Jul 2015, Caine was Asia BioProcess Specialist (BPS) Team Leader at Pall Corporation, based in Singapore. Prior to that, Caine was a Marketing Manager, Southeast Asia at Bio-Rad Laboratories, based in Singapore from Jan 2011 to Feb 2013. Caine started working as Business Manager, Asia Pacific at Bio-Rad Laboratories in Singapore in Jan 2010.
You can find Caine Leong's email address at finalscout.com. FinalScout is a free professional database with over five hundred million business professional profiles and over two hundred million company profiles.
Caine Leong's current jobs
I am responsible for driving growth and operational excellence in one of the world's most dynamic pharmaceutical and biotechnology markets. Merck BioReliance® is a trusted partner for contract testing services, supporting the development and manufacturing of life-saving therapies.
Caine Leong's past jobs
Leading the Southeast Asia sales and field applications team to drive sales growth for the Life Science Group products - Genomics, Proteomics, Droplet Digital PCR and Cell Biology.
Leading the Asia Marketing team to drive new product adoption through lead generation activities and campaigns. Created new approaches to accelerated new product adoption using a disciplined launch process that enabled sales and cross functional engagements. Core member of the global marketing council with oversight of new products development and setting of regional revenue goals.
Additional developmental role to lead 10-person Business Development team, to focus on seeding Pall’s technologies into new emerging biologics drug processes. Established the method to track new drugs development and manufacturing processes.
Lead Southeast Asian Marketing team to translate Global and Asian strategies into local tactics and actions to guide sales in exceeding regional revenue targets.
Responsible for identifying key growth markets and develop plans to expand Bio-Rad’s genomics portfolio to address these growing market needs. Initiated the development of CFX-IVD qPCR system for molecular diagnostics applications in the diagnosis and surveillance of emerging infectious diseases (H5N1, H1N1 and Dengue Serotyping).
Hired to provide technical support and sell Bio-Rad’s qPCR and Microarray instrumentation. Established key reference laboratories across SEA and developed Avian Influenza testing assay using Bio-Rad’s qPCR system.
Post-graduate cum Research Officer at the Laboratory of Molecular Endocrinology, leading the research in molecular and functional characterization of a putative oncogene HuUO-44 (GenBank accession no. NM_022034) in ovarian carcinogenesis. - Achieved funding in excess of S$280K from the National Medical Research Council (NMRC) for 2005 – 2007. - Awarded Avon Scholar in Training (2003) by the American Association for Cancer Research (AACR). - Published in Nature Publishing Groups journals such as Oncogene (2001 and 2003).